Health Products

IGIVnex (2012-02-25)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
26NP0R1IGIVnex
Recalling Firm
Grifols Canada Ltd
5060 Spectrum Way, Suite 405
Mississauga
L4W 5N5
Ontario
CANADA
Marketing Authorization Holder
Grifols Therapeutics Inc.
8368 US 70 Bus Hwy W
Clayton
27520
North Carolina
UNITED STATES
Solution for InjectionDIN 0227792110% 10g/100mL

Introduction

Recalled products
  1. IGIVnex

Reason

Precautionary measure due to an apparent higher rate of expected adverse reactions

Depth of distribution

Hospitals in Newfoundland and Labrador, Nova Scotia, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia via Canadian Blood Services
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime